We are live on ! Find out more
Cannell & Co

Cannell & Co Portfolio holdings

AUM $3.15B Turnover 11.43%
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$3.15B
AUM Growth
+$229M
Cap. Flow
-$67.4M
Cap. Flow %
-2.14%
Top 10 Hldgs %
30.6%
Holding
280
New
21
Increased
58
Reduced
115
Closed
11
Avg Time Held
5.5 years
Top 10 Avg Time Held
3.2 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$43.1M
2
LH icon
Labcorp
LH
+$27.4M
3
PINS icon
Pinterest
PINS
+$23.5M
4
GE icon
GE Aerospace
GE
+$18.2M
5
CSX icon
CSX
CSX
+$13.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$48.3M
2
VRT icon
Vertiv
VRT
+$31.6M
3
GPRE icon
Green Plains
GPRE
+$21.1M
4
KVUE icon
Kenvue
KVUE
+$19M
5
NTR icon
Nutrien
NTR
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.59%
2 Financials 15.93%
3 Industrials 13.18%
4 Healthcare 12.02%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PDBC icon
276
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.07B
– –
-28,496
Closed -$426K –
SCOR icon
277
Comscore
SCOR
$51.4M
– –
-19,508
Closed -$240K –
TMHC icon
278
DELISTED
Taylor Morrison
TMHC
– –
-5,000
Closed -$213K –
VEA icon
279
Vanguard FTSE Developed Markets ETF
VEA
$218B
– –
-9,851
Closed -$431K –
CEQP
280
DELISTED
Crestwood Equity Partners
CEQP
– –
-36,450
Closed -$1.07M –

Similar funds

Cannell & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Cannell & Co held 280 positions worth $3.15B, up 7.8% from $2.92B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co's Q4 2023 filing shows 21 new, 58 increased, 115 reduced and 11 closed positions. Its largest new stake was CRH: 714,012 shares worth $49.4M. The largest sale was Humana, an estimated $48.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Cannell & Co's largest Q4 2023 buy was CRH: 714,012 shares worth $49.4M.
  • Cannell & Co added most to Labcorp in Q4 2023, an estimated $27.4M increase.
  • Cannell & Co's biggest Q4 2023 reduction was Humana, cutting an estimated $48.3M.
  • Cannell & Co fully exited Nutrien in Q4 2023, selling an estimated $14.4M.
  • Cannell & Co's ten largest holdings make up 31% of its $3.15B portfolio in Q4 2023.
  • Cannell & Co opened 21 new positions and closed 11 in Q4 2023.
  • Cannell & Co's portfolio value rose 7.8% quarter-over-quarter to $3.15B.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.